首页> 外国专利> Compound, pharmaceutical formulation, use of a compound, methods for prevention and / or treatment of conditions associated with glycogen synthase kinase-3 and disease prevention and / or treatment, process for preparing a compound, and use of intermediates

Compound, pharmaceutical formulation, use of a compound, methods for prevention and / or treatment of conditions associated with glycogen synthase kinase-3 and disease prevention and / or treatment, process for preparing a compound, and use of intermediates

机译:化合物,药物制剂,化合物的用途,预防和/或治疗与糖原合酶激酶-3有关的病症和疾病的预防和/或治疗的方法,制备化合物的方法以及中间体的用途

摘要

"COMPOUND, PHARMACEUTICAL FORMULATION, USE OF A COMPOUND, METHODS FOR PREVENTION AND / OR TREATMENT OF CONDITIONS ASSOCIATED WITH GLYCOGEN SYNTASE KINASE-3 AND DISEASE PREVENTION AND / OR TREATMENT, PROCESS FOR AND PREPARATION OF THE PREPARATION, " The present invention relates to novel compounds of Formula (I) wherein Z is N; Y is CONR¬ 5¬, NR¬ 5¬CO, SO ~ 2 ~ NR¬ 5¬, NR¬ 5¬SO ~ 2 ~, CH ~ 2 ~ NR¬ 5¬, NR¬ 5¬, NR¬ 5¬CONR ¬ 5¬, CH ~ 2 ~ CO, CO, O or CH ~ 2 ~ O; X is CH or N; P is phenyl or a 5 or 6 membered heteroaromatic ring containing one or more heteroatoms selected from N, O or S and said phenyl ring or 5 or 6 membered heteroaromatic ring may optionally be fused to a 5 to 6 membered ring, saturated, partially saturated or unsaturated, containing one or more atoms selected from C, N, O or S; Q is C-1-6-alkyl, C-2-6-alkenyl, a process for its preparation and novel intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and the use of said active compounds in therapy, such as how to provide compounds having an inhibitory effect on GSK3.
机译:“化合物,药物制剂,化合物的使用,与糖原合酶激酶3和疾病预防和/或治疗有关的疾病的预防和/或治疗方法,制备方法和制备,”本发明涉及新颖的Z为N的式(I)化合物; Y是CONR 5-,NR 5 -CO,SO 2至NR 5-,NR 5 -SO 2至2,CH 2-NR 5 5,NR 5 5,NR 5 CONR ¬5¬,CH〜2〜CO,CO,O或CH〜2〜O; X为CH或N; P是苯基或含有一个或多个选自N,O或S的杂原子的5或6元杂芳族环,并且所述苯环或5或6元杂芳族环可以任选地稠合至5至6元饱和,部分饱和的环或不饱和的,含有一个或多个选自C,N,O或S的原子; Q是C-1-6-烷基,C-2-6-链烯基,其制备方法和其中使用的新型中间体,含有所述治疗活性化合物的药物制剂以及所述活性化合物在治疗中的用途,例如如何提供对GSK3具有抑制作用的化合物。

著录项

  • 公开/公告号BR0317299A

    专利类型

  • 公开/公告日2005-11-08

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号BR20030317299

  • 发明设计人 STEFAN BERG;SVEN HELLBERG;PETER SOEDERMAN;

    申请日2003-12-15

  • 分类号C07D403/12;C07D403/14;C07D401/12;C07D401/14;C07D413/14;A61K31/497;A61K31/496;A61K31/5377;A61P25/00;A61P3/10;A61P5/48;A61P15/18;A61P17/14;

  • 国家 BR

  • 入库时间 2022-08-21 22:18:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号